Development of recombinant cationic polymers for gene therapy research.

Cationic polymers created through recombinant DNA technology have the potential to fill a void in the area of gene delivery. The recombinant cationic polymers to be discussed here are amino acid based polymers synthesized in E. coli with the purpose to not only address the major barriers to efficient gene delivery but offer safety, biodegradability, targetability and cost-effectiveness. This review helps the readers to get a better understanding about the evolution of recombinant cationic polymers; and the potential advantages that they could offer over viral and synthetic non-viral vectors for gene delivery. It also discusses some of the major challenges that must be addressed in future studies to turn recombinant polymers into clinically effective gene delivery systems. Recent advances with the biopolymer design suggest that this emerging new class of gene delivery systems has the potential to address some of the major barriers to efficient, safe and cost-effective gene therapy.

[1]  A. Villaverde,et al.  A recombinant, arginine-glycine-aspartic acid (RGD) motif from foot-and-mouth disease virus binds mammalian cells through vitronectin and, to a lower extent, fibronectin receptors. , 1996, Gene.

[2]  D. Scherman,et al.  A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[3]  J. Rodríguez‐Cabello,et al.  Influence of the Molecular Weight on the Inverse Temperature Transition of a Model Genetically Engineered Elastin-like pH-Responsive Polymer , 2004 .

[4]  C. Benz,et al.  Increased target specificity of anti-HER2 genospheres by modification of surface charge and degree of PEGylation. , 2006, Molecular pharmaceutics.

[5]  Andrew D. Miller,et al.  Kinetic study of DNA condensation by cationic peptides used in nonviral gene therapy: analogy of DNA condensation to protein folding. , 2003, Biochemistry.

[6]  T. Chen,et al.  Intelligent Biosynthetic Nanobiomaterials (IBNs) for Hyperthermic Gene Delivery , 2008, Pharmaceutical Research.

[7]  Jun Li,et al.  Low molecular weight polyethylenimine cross-linked by 2-hydroxypropyl-gamma-cyclodextrin coupled to peptide targeting HER2 as a gene delivery vector. , 2010, Biomaterials.

[8]  Gerrit Borchard,et al.  Transfection efficiency and toxicity of polyethylenimine in differentiated Calu-3 and nondifferentiated COS-1 cell cultures , 2002, AAPS PharmSci.

[9]  J. Khadake,et al.  Condensation of DNA and chromatin by an SPKK-containing octapeptide repeat motif present in the C-terminus of histone H1. , 1997, Biochemistry.

[10]  Yuhua Wang,et al.  Biosynthesis and characterization of a novel genetically engineered polymer for targeted gene transfer to cancer cells. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[11]  Mark A. Kay,et al.  Progress and problems with the use of viral vectors for gene therapy , 2003, Nature Reviews Genetics.

[12]  C. Joo,et al.  Fueling protein–DNA interactions inside porous nanocontainers , 2007, Proceedings of the National Academy of Sciences.

[13]  Yifeng Li.  Carrier proteins for fusion expression of antimicrobial peptides in Escherichia coli , 2009, Biotechnology and applied biochemistry.

[14]  A. Hatefi,et al.  Perspectives in vector development for systemic cancer gene therapy. , 2009, Gene therapy & molecular biology.

[15]  Shubiao Zhang,et al.  Toxicity of cationic lipids and cationic polymers in gene delivery. , 2006, Journal of controlled release : official journal of the Controlled Release Society.

[16]  Yuhua Wang,et al.  Evaluation of the effect of vector architecture on DNA condensation and gene transfer efficiency. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[17]  T. Yang,et al.  Antitumor Effect of Paclitaxel-Loaded PEGylated Immunoliposomes Against Human Breast Cancer Cells , 2007, Pharmaceutical Research.

[18]  D. Lauffenburger,et al.  Receptor‐mediated targeting of gene delivery vectors: Insights from molecular mechanisms for improved vehicle design , 2000, Biotechnology and bioengineering.

[19]  J. Wade,et al.  Overview of Solid Phase Synthesis of “Difficult Peptide” Sequences , 2007, Current protocols in protein science.

[20]  G. Dreyfuss,et al.  A nuclear localization domain in the hnRNP A1 protein , 1995, The Journal of cell biology.

[21]  A. Hatefi,et al.  Recombinant polymer‐protein fusion: a promising approach towards efficient and targeted gene delivery , 2006, The journal of gene medicine.

[22]  A. Demain,et al.  Production of recombinant proteins by microbes and higher organisms. , 2009, Biotechnology advances.

[23]  R. Balhorn,et al.  Condensation of DNA by Spermatid Basic Nuclear Proteins* , 2002, The Journal of Biological Chemistry.

[24]  D. Urry.  Physical Chemistry of Biological Free Energy Transduction As Demonstrated by Elastic Protein-Based Polymers† , 1997 .

[25]  A. Villaverde,et al.  Exploiting viral cell-targeting abilities in a single polypeptide, non-infectious, recombinant vehicle for integrin-mediated DNA delivery and gene expression. , 2000, Biotechnology and bioengineering.

[26]  J. Carlsson,et al.  Tumor imaging using a picomolar affinity HER2 binding affibody molecule. , 2006, Cancer research.

[27]  H. Harashima,et al.  Advances in non-viral gene delivery: using multifunctional envelope-type nano-device , 2008 .

[28]  Daniel W. Pack,et al.  Design and development of polymers for gene delivery , 2005, Nature Reviews Drug Discovery.

[29]  Ashutosh Chilkoti,et al.  Genetically encoded synthesis of protein-based polymers with precisely specified molecular weight and sequence by recursive directional ligation: examples from the elastin-like polypeptide system. , 2002, Biomacromolecules.